vs

Side-by-side financial comparison of HURCO COMPANIES INC (HURC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $45.5M, roughly 1.7× HURCO COMPANIES INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $3.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.5%).

Hurco Companies Inc is a global industrial technology firm that designs, manufactures and sells CNC machine tools, including machining centers, turning centers, and proprietary control software. It serves aerospace, automotive, energy, and general metalworking customers across North America, Europe and Asia Pacific.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

HURC vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.7× larger
PBYI
$75.5M
$45.5M
HURC
Growing faster (revenue YoY)
PBYI
PBYI
+43.1% gap
PBYI
27.7%
-15.3%
HURC
More free cash flow
PBYI
PBYI
$10.7M more FCF
PBYI
$14.4M
$3.6M
HURC
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
0.5%
HURC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HURC
HURC
PBYI
PBYI
Revenue
$45.5M
$75.5M
Net Profit
$-3.0M
Gross Margin
17.0%
69.3%
Operating Margin
-7.6%
22.7%
Net Margin
-6.7%
Revenue YoY
-15.3%
27.7%
Net Profit YoY
-110.9%
EPS (diluted)
$-0.47
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HURC
HURC
PBYI
PBYI
Q4 25
$45.5M
$75.5M
Q3 25
$45.8M
$54.5M
Q2 25
$40.9M
$52.4M
Q1 25
$46.4M
$46.0M
Q4 24
$53.7M
$59.1M
Q3 24
$42.7M
$80.5M
Q2 24
$45.2M
$47.1M
Q1 24
$45.1M
$43.8M
Net Profit
HURC
HURC
PBYI
PBYI
Q4 25
$-3.0M
Q3 25
$-3.7M
$8.8M
Q2 25
$-4.1M
$5.9M
Q1 25
$-4.3M
$3.0M
Q4 24
$-1.4M
Q3 24
$-9.6M
$20.3M
Q2 24
$-3.9M
$-4.5M
Q1 24
$-1.6M
$-4.8M
Gross Margin
HURC
HURC
PBYI
PBYI
Q4 25
17.0%
69.3%
Q3 25
19.9%
77.7%
Q2 25
19.2%
76.5%
Q1 25
17.9%
77.1%
Q4 24
22.7%
76.4%
Q3 24
18.4%
63.9%
Q2 24
17.8%
77.4%
Q1 24
21.5%
75.5%
Operating Margin
HURC
HURC
PBYI
PBYI
Q4 25
-7.6%
22.7%
Q3 25
-3.6%
17.6%
Q2 25
-7.5%
12.7%
Q1 25
-4.5%
8.7%
Q4 24
-0.9%
22.6%
Q3 24
-5.9%
27.4%
Q2 24
-7.6%
-4.6%
Q1 24
-4.0%
-5.3%
Net Margin
HURC
HURC
PBYI
PBYI
Q4 25
-6.7%
Q3 25
-8.1%
16.2%
Q2 25
-9.9%
11.2%
Q1 25
-9.3%
6.5%
Q4 24
-2.7%
Q3 24
-22.5%
25.2%
Q2 24
-8.7%
-9.6%
Q1 24
-3.7%
-11.0%
EPS (diluted)
HURC
HURC
PBYI
PBYI
Q4 25
$-0.47
$0.26
Q3 25
$-0.58
$0.17
Q2 25
$-0.62
$0.12
Q1 25
$-0.67
$0.06
Q4 24
$-0.23
$0.40
Q3 24
$-1.47
$0.41
Q2 24
$-0.61
$-0.09
Q1 24
$-0.25
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HURC
HURC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$48.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$198.8M
$130.3M
Total Assets
$264.3M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HURC
HURC
PBYI
PBYI
Q4 25
$48.7M
$97.5M
Q3 25
$44.5M
$94.4M
Q2 25
$43.8M
$96.0M
Q1 25
$41.8M
$93.2M
Q4 24
$33.3M
$101.0M
Q3 24
$36.1M
$96.7M
Q2 24
$37.5M
$96.8M
Q1 24
$37.9M
$107.2M
Total Debt
HURC
HURC
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
HURC
HURC
PBYI
PBYI
Q4 25
$198.8M
$130.3M
Q3 25
$203.7M
$115.3M
Q2 25
$202.3M
$104.7M
Q1 25
$198.1M
$97.1M
Q4 24
$207.2M
$92.1M
Q3 24
$206.6M
$71.1M
Q2 24
$215.6M
$48.5M
Q1 24
$224.6M
$51.0M
Total Assets
HURC
HURC
PBYI
PBYI
Q4 25
$264.3M
$216.3M
Q3 25
$269.1M
$202.9M
Q2 25
$262.5M
$194.9M
Q1 25
$255.8M
$196.2M
Q4 24
$268.6M
$213.3M
Q3 24
$272.4M
$220.7M
Q2 24
$280.8M
$205.0M
Q1 24
$290.1M
$214.1M
Debt / Equity
HURC
HURC
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HURC
HURC
PBYI
PBYI
Operating Cash FlowLast quarter
$3.7M
$14.4M
Free Cash FlowOCF − Capex
$3.6M
$14.4M
FCF MarginFCF / Revenue
8.0%
19.1%
Capex IntensityCapex / Revenue
0.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$16.7M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HURC
HURC
PBYI
PBYI
Q4 25
$3.7M
$14.4M
Q3 25
$2.5M
$9.7M
Q2 25
$997.0K
$14.1M
Q1 25
$10.3M
$3.6M
Q4 24
$-1.2M
$15.6M
Q3 24
$-622.0K
$11.0M
Q2 24
$1.9M
$1.0M
Q1 24
$-2.6M
$11.2M
Free Cash Flow
HURC
HURC
PBYI
PBYI
Q4 25
$3.6M
$14.4M
Q3 25
$2.1M
$9.7M
Q2 25
$689.0K
$14.1M
Q1 25
$10.2M
$3.6M
Q4 24
$-1.7M
$15.6M
Q3 24
$-841.0K
$11.0M
Q2 24
$1.7M
$1.0M
Q1 24
$-3.0M
FCF Margin
HURC
HURC
PBYI
PBYI
Q4 25
8.0%
19.1%
Q3 25
4.5%
17.7%
Q2 25
1.7%
26.8%
Q1 25
22.1%
7.7%
Q4 24
-3.1%
26.4%
Q3 24
-2.0%
13.7%
Q2 24
3.9%
2.1%
Q1 24
-6.7%
Capex Intensity
HURC
HURC
PBYI
PBYI
Q4 25
0.1%
0.0%
Q3 25
1.0%
0.0%
Q2 25
0.8%
0.0%
Q1 25
0.2%
0.1%
Q4 24
0.8%
0.0%
Q3 24
0.5%
0.0%
Q2 24
0.3%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
HURC
HURC
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HURC
HURC

Computerized Machine Tools$35.9M79%
Service Parts$6.7M15%
Service Fees$2.3M5%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons